In the T lymphocytes of SARS-CoV-2-infected women with pneumonia, the DCA–VPA treatment changed the expression of 11 genes: it increased the expression of IL11, IL1A, IL1B, IL23A, IL24, CCL20, CXCL2, CXCL8, BMP6, and NODAL, and decreased the expression of CSF3. This evidence concerns the gene IL1B and susceptibility to pneumonia measurement.